Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AZN wins the EU nod for Imfinzi in early gastric and GEJ cancers, backed by strong survival data and expanding…

Astrazeneca (AZN) concluded the recent trading session at $189.9, signifying a -1.35% move from its prior days close.…

Image source: The Motley Fool.DATEThursday, March 12, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Jon CongletonChief Financial Officer…

Sie erhält eine Covid-Impfung und erleidet einen Hörsturz. Nun hat die Frau den Rechtsstreit mit dem Impfstoffhersteller AstraZeneca vor den…

Vor dem Bundesgerichtshof geht es heute um mögliche Ansprüche nach einer Corona-Impfung. Eine Klägerin verlangt Schadensersatz und Auskunft vom Hersteller…

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has…

Exxon Mobil, Palantir and AstraZeneca lead Zacks latest analyst reports, highlighting strong production growth, AI momentum and a robust drug…

Exxon Mobil leads fresh analyst reports as Permian and Guyana output power growth, while Palantirs AI platforms and AstraZenecas drug…

Image source: The Motley Fool.DATEMarch 3, 2026, 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Jurgi CamblongChief Financial Officer — George…

Looking back, it almost seems like a dream. On Aug. 31, 2020, the U.S. had just surpassed six million COVID-19…

By John Vandermosten, CFANASDAQ:LNTHLantheus Reports 2025 Financial and Operational Results Lantheus Holdings, Inc. (NASDAQ:LNTH) reported financial results yesterday. Revenue was…

The long-term growth story for AstraZeneca PLC beyond 2030 is increasingly focused on next-generation cell therapies and immune engagers, according to UBS,...…

Image source: The Motley Fool.DATEWednesday, Feb. 25, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Terry J. RosenPresident —…

Image source: The Motley Fool.DateFeb. 25, 2026 at 4:30 p.m. ETCall participantsChairman and Chief Executive Officer — Niccolo de MasiChief…

AZNs stronger growth outlook and 2030 revenue target may outshine PFEs yield and cheaper valuation.…

20 February 2026Calquence plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukaemia in…

In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal…

In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal…

Lund, Sweden — 17 February 2026 — Camurus (NASDAQ STO: CAMX) today announced that Jane Buus Laursen has been appointed…

…

Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...…

Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...…